跳至主要内容
临床试验/NCT03878355
NCT03878355已完成不适用

Long-term Outcomes of Radical Endoscopic Sinus Surgery Plus Draf 3 Procedure in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps and Asthma: A 9-year Prospective Study

Beijing Tongren Hospital0 个研究点目标入组 27 人开始时间: 2010年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
主要终点
recurrence

研究概览

简要总结

CRS remains a common challenging clinical entity due to variable phenotypes with different underlying mechanisms that lead to persistence or recurrence polyps. The eosinophils dominant inflammation was considered as a major pathological hallmark and challenges of CRS with nasal polyps (CRSwNP). Differentiate surgical approaches towards eosinophilic CRSwNP (eCRSwNP) should be addressed on the basis of the inflammatory endotypes. eCRSwNP has been recognized as the most easily relapsed type of CRS, and the combination of asthma increases the difficulty of treatment. Till now there is no recognized surgical strategy for eCRSwNP with asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
24 Years 至 71 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The diagnosis of CRSwNP was based on the standard criteria issued in the European Position Paper on Rhinosinusitis and Nasal Polyps guidelines.
  • Participants had at least 1 previous sinus surgery underwent FESS (middle turbinate (MT) preserved), good gasification of frontal sinus and with concomitant asthma.
  • The diagnosis of asthma was confirmed by a chest physician according to Global Initiative for Asthma (GINA) guidelines.
  • Polyp biopsy was undertaken 1 week before surgery and the eCRSwNP was confirmed by the number of eosinophils exceeded 10% of total infiltrating inflammatory cells in the polyp tissue through the evaluation by using hematoxylin and eosin (H&E) staining.

排除标准

  • Patients were excluded if they had unilateral disease, allergic fungal rhinosinusitis, antrochoanal polyps, or cysts.

研究组 & 干预措施

functional endoscopic sinus surgery

Experimental

干预措施: functional endoscopic sinus surgery (FESS) (Procedure)

radical endoscopic sinus surgery plus Draf 3 surgery

Experimental

干预措施: radical endoscopic sinus surgery (RESS) plus Draf 3 surgery. (Procedure)

radical endoscopic sinus surgery

Experimental

干预措施: radical endoscopic sinus surgery (RESS) (Procedure)

结局指标

主要结局

recurrence

时间窗: 5 years after surgery

Recurrence was defined if the patient had symptoms of chronic rhinosinusitis after surgery, and nasal endoscopy found nasal polyps recurrence, obvious edema of mucosa, or purulent secretion, and above of symptoms or physical signs existed, which can't be alleviated by maximum medicine treatment at least 1 month

次要结局

  • Visual analogue scale of 4 major clinical symptoms(at baseline, and 1 year, 3years, 5 years after surgery)
  • Sinus-specific quality of life (QoL)(at baseline, and 1 year, 3years, 5 years after surgery)
  • Postoperatively endoscopic results(at baseline, and 1 year, 3years, 5 years after surgery)

研究者

发起方
Beijing Tongren Hospital
申办方类型
Other
责任方
Sponsor

相似试验